Skip to content

Assessment the effect of implementation of discharge plan on anxiety in patients with diabetes mellitus

Assessment the effect of implementation of discharge plan on physiological and behavioral anxiety parameters in patients with diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181112041627N1
Enrollment
80
Registered
2018-12-24
Start date
2018-12-22
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: implementation an educational program during discharge with the general definition of diabetes, blood glucose control, diet, exercise and activity, acute complicati

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: age more than eighteen years ability to reading and writing ability to understand and speak in Farsi ability to self care ability to speech and hearing absence of dementia and cognitive problem absence of endocrine gland diseases not taking medications that reduce or increase cortisol (such as corticosteroids, anticonvulsants) not taking anti-anxiety and tranquilizers (such as propranolol, clonazepam, etc.) There is no underlying diseases desire to participate in the study

Exclusion criteria

Exclusion criteria: Not fasting Brushing during recent 4-5 hours Not having saliva (in some cases like Sjogren's syndrome) Presence of gingivitis Unwilling to continue research Discharge of the patient after 10 o'clock (due to stable salivary cortisol levels between 7 and 10 o'clock)

Design outcomes

Primary

MeasureTime frame
Anxiety Score in Beck's questionnaire. Timepoint: Anxiety Measurement at the beginning of the study (before the intervention) and half an hour after the intervention. Method of measurement: Anxiety Beck's questionnaire.;Salivary cortisol levels based on micrograms per deciliter. Timepoint: Anxiety Measurement at the beginning of the study (before the intervention) and half an hour after the intervention. Method of measurement: Saliva sample.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Fooladzadeh

Tehran University of Medical Sciences

fooladzadeh8343@gmail.com+98 58 3622 4373

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026